Sovereign Pharmaceuticals, LLC

Form 483 issued August 2, 2023 · Fort Worth, Texas

Investigators
A. Ol· Christopher N. Tran
Observations
3
Pages
6
FEI number
3003229412

In short: On August 2, 2023, FDA issued a Form 483 with 3 observations to Sovereign Pharmaceuticals, LLC in Fort Worth, Texas (FEI 3003229412). The investigators were A. Ol and Christopher N. Tran. Most observations concern quality system and laboratory controls.

At a glance

Quality system and laboratory controls account for 2 of 3 observations.

Quality system1
Laboratory controls1
Materials1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Laboratory controls do not include the establishment of scientifically sound and appropriate specifications and test procedures…

  3. 03

    Component testing is deficient in that each component is not tested for conformity with all appropriate…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sovereign Pharmaceuticals, LLC?

FDA listed 3 observations on this Form 483, mostly about quality system, laboratory controls and materials. The opening words of each observation are shown on this page.

Who inspected Sovereign Pharmaceuticals, LLC?

A. Ol and Christopher N. Tran are named on this Form 483. Each investigator has a profile showing what they cite most.

When was Sovereign Pharmaceuticals, LLC inspected by FDA?

This Form 483 is dated August 2, 2023.

How do I get the full Form 483 for Sovereign Pharmaceuticals, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free